Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | TAS1R3 | Q7RTX0 | 7/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 7/20 | 0.46 |
| ▸ | TAS1R2 | Q8TE23 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PLAU | P00749 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29433242 | 0.98 | ALDH1A1 (0.64) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL3779532 | 0.91 | ALDH1A1 (0.59) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL24293373 | 0.91 | ALDH1A1 (0.62) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL29786135 | 0.90 | ALDH1A1 (0.73) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL27198368 | 0.90 | ALDH1A1 (0.73) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL26646529 | 0.90 | ALDH1A1 (0.61) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| Trimethylammonium SCHEMBL1701713 | 0.86 | ALDH1A1 (0.68) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL25397182 | 0.86 | ALDH1A1 (0.68) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL21318173 | 0.86 | ALDH1A1 (0.68) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL29786129 | 0.86 | ALDH1A1 (0.68) | ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365493-A1 | COMPOUNDS AND METHODS | DemAgtech Pty Ltd (AU) | 2023-11-16 | — | — | US | disclosed |
| US-20230365493-A1 | COMPOUNDS AND METHODS | DemAgtech Pty Ltd (AU) | 2023-11-16 | — | — | US | disclosed |
| US-20230365493-A1 | COMPOUNDS AND METHODS | DemAgtech Pty Ltd (AU) | 2023-11-16 | — | — | US | disclosed |
| WO-2023168484-A1 | \"COMPOUNDS AND METHODS\ | DemAgtech Pty Ltd (AU) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023168484-A1 | \"COMPOUNDS AND METHODS\ | DemAgtech Pty Ltd (AU) | 2023-09-14 | — | — | WO | disclosed |
| EP-4211108-A1 | COMPOUNDS AND METHODS | Demagtech Pty Ltd (AU) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022051804-A1 | COMPOUNDS AND METHODS | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022051804-A1 | COMPOUNDS AND METHODS | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365493-A1 | COMPOUNDS AND METHODS | DDT, CYP19A1, CYP1A1 | ALDH1A1 86/4885TSHR 2347/4885KDM4E 1979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.